These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation. Kupers R; Frokjaer VG; Naert A; Christensen R; Budtz-Joergensen E; Kehlet H; Knudsen GM Neuroimage; 2009 Feb; 44(3):1001-7. PubMed ID: 19007894 [TBL] [Abstract][Full Text] [Related]
3. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain. Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220 [TBL] [Abstract][Full Text] [Related]
4. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin. Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study. Marner L; Knudsen GM; Haugbøl S; Holm S; Baaré W; Hasselbalch SG Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):287-93. PubMed ID: 18828013 [TBL] [Abstract][Full Text] [Related]
6. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans. Erritzoe D; Holst K; Frokjaer VG; Licht CL; Kalbitzer J; Nielsen FA; Svarer C; Madsen J; Knudsen G J Neurosci; 2010 Mar; 30(9):3391-7. PubMed ID: 20203198 [TBL] [Abstract][Full Text] [Related]
7. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography. Mintun MA; Sheline YI; Moerlein SM; Vlassenko AG; Huang Y; Snyder AZ Biol Psychiatry; 2004 Feb; 55(3):217-24. PubMed ID: 14744461 [TBL] [Abstract][Full Text] [Related]
8. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET. Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031 [TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users. Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575 [TBL] [Abstract][Full Text] [Related]
10. Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography. Quednow BB; Treyer V; Hasler F; Dörig N; Wyss MT; Burger C; Rentsch KM; Westera G; Schubiger PA; Buck A; Vollenweider FX Neuroimage; 2012 Feb; 59(4):3922-32. PubMed ID: 21996132 [TBL] [Abstract][Full Text] [Related]
11. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Adams KH; Hansen ES; Pinborg LH; Hasselbalch SG; Svarer C; Holm S; Bolwig TG; Knudsen GM Int J Neuropsychopharmacol; 2005 Sep; 8(3):391-401. PubMed ID: 15801987 [TBL] [Abstract][Full Text] [Related]